Clinical Trials
3 trialsNCT00323063 2023-03-29
Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT00193180 2016-05-27
Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00087152 2014-06-09
S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed